Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses - PubMed (original) (raw)
Review
Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses
Tetsuo Shiohara et al. Allergol Int. 2006 Mar.
Free article
Abstract
A relationship between viral infections and the simultaneous or subsequent development of allergic inflammation has often been observed in various clinical situations. Recent studies suggest an intimate relationship between reactivations of herpesviruses including human herpesvirus 6 (HHV-6) and the development of a severe systemic hypersensitivity reaction referred to as drug-induced hypersensitivity syndrome (DIHS). This syndrome has several important clinical features that cannot be solely explained by drug antigen-driven oligoclonal expansion of T cells: they include paradoxical worsening of clinical symptoms after discontinuation of the causative drug. In view of the similarity to GVHD or immune reconstitution syndrome (IRS) in clinical manifestations and emergence of viral infections, the clinical symptoms observed during the course of DIHS and GVHD are likely to be mediated by antiviral T cells that can cross-react with the drug and alloantigens, respectively. In considering common intrinsic properties of the causative drugs to potentially induce immunosuppression, reconstitution of a valid immune response to these viruses, which is typically observed in IRS, may be the most crucial process that takes place after withdrawal of the causative drug in patients with DIHS. Thus, this syndrome should be regarded as a reaction induced by a complex interplay among several herpesviruses (EB virus, HHV-6, HHV-7, and cytomegalovirus), antiviral immune responses, and drug-specific immune responses. This review includes discussion of the pathomechanism, the clinical symptoms, laboratory findings, pathological findings and therapy.
Similar articles
- Virus reactivation and intravenous immunoglobulin (IVIG) therapy of drug-induced hypersensitivity syndrome.
Kano Y, Inaoka M, Sakuma K, Shiohara T. Kano Y, et al. Toxicology. 2005 Apr 15;209(2):165-7. doi: 10.1016/j.tox.2004.12.013. Toxicology. 2005. PMID: 15767030 Review. - The variable clinical picture of drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug.
Kano Y, Shiohara T. Kano Y, et al. Immunol Allergy Clin North Am. 2009 Aug;29(3):481-501. doi: 10.1016/j.iac.2009.04.007. Immunol Allergy Clin North Am. 2009. PMID: 19563993 Review. - Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution.
Ushigome Y, Kano Y, Ishida T, Hirahara K, Shiohara T. Ushigome Y, et al. J Am Acad Dermatol. 2013 May;68(5):721-8. doi: 10.1016/j.jaad.2012.10.017. Epub 2012 Nov 20. J Am Acad Dermatol. 2013. PMID: 23182063 - Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome.
Tohyama M, Hashimoto K, Yasukawa M, Kimura H, Horikawa T, Nakajima K, Urano Y, Matsumoto K, Iijima M, Shear NH. Tohyama M, et al. Br J Dermatol. 2007 Nov;157(5):934-40. doi: 10.1111/j.1365-2133.2007.08167.x. Epub 2007 Sep 13. Br J Dermatol. 2007. PMID: 17854362 - Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
Seishima M, Yamanaka S, Fujisawa T, Tohyama M, Hashimoto K. Seishima M, et al. Br J Dermatol. 2006 Aug;155(2):344-9. doi: 10.1111/j.1365-2133.2006.07332.x. Br J Dermatol. 2006. PMID: 16882173
Cited by
- ALDRESS: A Retrospective Pilot Study to Develop a Pharmacological Causality Algorithm for Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
Stewart S, Gómez López de Las Huertas A, Jiménez-González M, Carcas AJ, Borobia AM, Ramírez E. Stewart S, et al. J Clin Med. 2024 Apr 29;13(9):2622. doi: 10.3390/jcm13092622. J Clin Med. 2024. PMID: 38731156 Free PMC article. - Drug-induced hypersensitivity syndrome related to piperacillin-tazobactam: a case report and review of the literature.
Shen Y, Cui SS, Teng XB, Han MF. Shen Y, et al. Front Med (Lausanne). 2024 Mar 28;11:1338247. doi: 10.3389/fmed.2024.1338247. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38606160 Free PMC article. - Valacyclovir as Etiology for Drug Reaction with Eosinophilia and Systemic Symptoms: A Case Report.
Downs D, Sivakolundu K, Lim N, Kandula M. Downs D, et al. J Community Hosp Intern Med Perspect. 2023 Nov 4;13(6):8-12. doi: 10.55729/2000-9666.1248. eCollection 2023. J Community Hosp Intern Med Perspect. 2023. PMID: 38596552 Free PMC article. - Clinical Presentation and Diagnosis of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review.
St George-Hyslop F, Cherepacha N, Chugani B, Alabdeen Y, Sanchez-Espino LF, Mahood Q, Sibbald C, Verstegen RHJ. St George-Hyslop F, et al. Clin Rev Allergy Immunol. 2024 Feb;66(1):112-123. doi: 10.1007/s12016-024-08983-7. Epub 2024 Mar 11. Clin Rev Allergy Immunol. 2024. PMID: 38466562 Review. - Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome secondary to antimicrobial therapy in pediatric bone and joint infections.
Yildirim Arslan S, Sahbudak Bal Z, Guner Ozenen G, Bilen NM, Avcu G, Erci E, Kurugol Z, Gunay H, Tamsel İ, Ozkinay F. Yildirim Arslan S, et al. World Allergy Organ J. 2024 Feb 7;17(2):100850. doi: 10.1016/j.waojou.2023.100850. eCollection 2024 Feb. World Allergy Organ J. 2024. PMID: 38370132 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical